Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer

Fig. 2

RFS outcomes according to ctDNA status in the discovery cohort. A The recurrence rate for patients stratified by postoperative ctDNA status. B Kaplan-Meier curves of RFS for patients stratified by postoperative ctDNA status. C and D Kaplan-Meier curves of RFS for patients stratified by postoperative ctDNA status in the subset of patients with or without ACT administration. CRC colorectal cancer, RFS recurrence-free survival, ctDNA circulating tumor DNA, ACT adjuvant chemotherapy

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us